Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label crossover single-dose study of prolonged-release torasemide, immediate-release torasemide, and immediate-release furosemide in compensated heart failure
2011-000972-32Phase 4Active
- Sponsor
- Ferrer
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of torasemide and furosemide in heart failure (HF) (3 arms), sponsored by Ferrer. Primary endpoint: Natriuretic efficiency. Started Jan 2012; status: active.
02
Drugs
torasemidefurosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2011-000972-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000972-32.